JSPR - Jasper Therapeutics, Inc.
IEX Last Trade
22.5
0.190 0.844%
Share volume: 3,026
Last Updated: Thu 26 Dec 2024 08:28:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$22.31
0.19
0.85%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-1.85%
1 Month
-4.07%
3 Months
15.23%
6 Months
3.48%
1 Year
275.87%
2 Year
291.88%
Key data
Stock price
$22.50
DAY RANGE
$21.89 - $22.79
52 WEEK RANGE
$7.00 - $31.01
52 WEEK CHANGE
$202.41
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Ronald A. Martell
Region: US
Website: www.jaspertherapeutics.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: www.jaspertherapeutics.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.
Recent news